| RS1064796762 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796764 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS1064796765 |
DYNC1H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS1064796766 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1064796768 |
PARN
|
Health Risk |
Pathogenic |
— |
| RS1064796771 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796772 |
ASXL1
|
Health Risk |
Pathogenic |
— |
| RS1064796774 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Inborn genetic diseases |
| RS1064796776 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796777 |
ANOS1
|
Health Risk |
Pathogenic |
— |
| RS1064796781 |
WFS1
|
Health Risk |
Pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1064796787 |
CLN6
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS1064796790 |
SMC3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796791 |
AFG2A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796793 |
CNGB3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796797 |
FLNB
|
Health Risk |
Likely pathogenic |
— |
| RS1064796799 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS1064796800 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS1064796803 |
STAMBP
|
Health Risk |
Likely pathogenic |
— |
| RS1064796804 |
AFG3L2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796806 |
NONO
|
Health Risk |
Pathogenic |
— |
| RS1064796807 |
PDHX
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS1064796809 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS1064796811 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brain small vessel disease 1 with or without ocular anomalies, Brain small vessel disease 1 with or without ocular anomalies |
| RS1064796813 |
KMT2C
|
Health Risk |
Likely pathogenic |
— |
| RS1064796814 |
LOX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796818 |
AFF2
|
Health Risk |
Pathogenic |
— |
| RS1064796819 |
PQBP1
|
Health Risk |
Pathogenic |
— |
| RS1064796820 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS1064796823 |
FOXG1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796824 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796827 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS1064796830 |
PURA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1064796832 |
SLC2A10
|
Health Risk |
Pathogenic |
— |
| RS1064796833 |
HCFC1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796835 |
TCOF1
|
Health Risk |
Pathogenic |
— |
| RS1064796836 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1064796837 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS1064796843 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1064796845 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064796849 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064796851 |
HIBCH
|
Health Risk |
Likely pathogenic |
— |
| RS1064796853 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1064796854 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS1064796855 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1064796857 |
NHEJ1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796858 |
P3H2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796859 |
RPS7
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS1064796861 |
TRIP12
|
Health Risk |
Pathogenic |
— |
| RS1064796862 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1064796866 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796867 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796868 |
PHIP
|
Health Risk |
Pathogenic/Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1064796872 |
SHANK3
|
Health Risk |
Pathogenic |
Schizophrenia 15, Phelan-McDermid syndrome |
| RS1064796877 |
BRAT1
|
Health Risk |
Pathogenic |
— |
| RS1064796879 |
CASK
|
Health Risk |
Pathogenic |
CASK-related disorder, CASK-related disorder |
| RS1064796882 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1064796884 |
CASK
|
Health Risk |
Likely pathogenic |
— |
| RS1064796885 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1064796886 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1064796889 |
MEN1
|
Health Risk |
Pathogenic |
— |
| RS1064796892 |
BCKDHB
|
Health Risk |
Pathogenic |
— |
| RS1064796893 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS1064796899 |
RBBP8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064796901 |
GABRB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796903 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS1064796907 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS1064796911 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS1064796912 |
PIEZO1
|
Health Risk |
Pathogenic |
— |
| RS1064796914 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS1064796916 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS1064796919 |
SIN3A
|
Health Risk |
Pathogenic |
— |
| RS1064796922 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796923 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1064796924 |
DDX3X
|
Health Risk |
Likely pathogenic |
— |
| RS1064796925 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS1064796926 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1064796927 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064796928 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1064796929 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS1064796938 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS1064796939 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1064796940 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796941 |
NOG
|
Health Risk |
Likely pathogenic |
— |
| RS1064796942 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064796945 |
PTCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796946 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796948 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1064796950 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1064796954 |
POU1F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS1064796955 |
SLC34A3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796956 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS1064796960 |
SALL1
|
Health Risk |
Pathogenic |
— |
| RS1064796961 |
CLPB
|
Health Risk |
Likely pathogenic |
— |
| RS1064796964 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064796970 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1064796972 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS1064796974 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1064796977 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796981 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |